Xiaoling Li
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Immunology top 2%
- Immunotherapy and Immune Responses
Papers in
-
- Chromatin Remodeling and Cancer 13
- RNA modifications and cancer 12
- Protein Degradation and Inhibitors 10
- Cancer-related gene regulation 10
-
- Lung Cancer Treatments and Mutations 12
- Ferroptosis and cancer prognosis 11
- Co-authors
- Guiyuan Li (55 shared papers)Wei Xiong (27 shared papers)Zhaoyang Zeng (26 shared papers)Can Guo (8 shared papers)Yong Li (8 shared papers)Bo Xiang (22 shared papers)Ming Zhou (19 shared papers)Yongzhen Mo (6 shared papers)
- Journals
- Molecular Cancer (6 papers)Journal of Biological Chemistry (6 papers)Journal of Cancer (4 papers)Journal of Experimental & Clinical Cancer Research (4 papers)Cancer Letters (4 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Xiaoling Li
217 papers receiving 6.9k citations
Xiaoling Li's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.5k
- Immunology 1.2k
- Molecular Biology 3.2k
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 960
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 224 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoantigen vaccine: an emerging tumor immunotherapy Hit paper breakdown → | 2019 | 543 |
| 2 | The role of microenvironment in tumor angiogenesis Hit paper breakdown → | 2020 | 541 |
| 3 | 2017 | 308 | |
| 4 | Single‐cell RNA sequencing in cancer research Hit paper breakdown → | 2021 | 256 |
| 5 | 2019 | 200 | |
| 6 | 2021 | 152 | |
| 7 | 2018 | 145 | |
| 8 | 2003 | 144 | |
| 9 | 2006 | 131 | |
| 10 | 2017 | 117 | |
| 11 | 2008 | 111 | |
| 12 | 2021 | 100 | |
| 13 | 2021 | 99 | |
| 14 | 2017 | 98 | |
| 15 | 2008 | 96 | |
| 16 | 2022 | 96 | |
| 17 | 2009 | 91 | |
| 18 | 2021 | 87 | |
| 19 | 2020 | 87 | |
| 20 | 2021 | 84 |
About Xiaoling Li
Xiaoling Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 224 papers that have together received 7.0k indexed citations. Recurring topics across this work include Chromatin Remodeling and Cancer (13 papers), Lung Cancer Treatments and Mutations (12 papers), RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (11 papers), Ferroptosis and cancer prognosis (11 papers), Protein Degradation and Inhibitors (10 papers), Cancer-related gene regulation (10 papers) and Irrigation Practices and Water Management (9 papers). The work is most often cited by research in Cancer Research (1.5k citations), Immunology (1.2k citations), Molecular Biology (3.2k citations), Oncology (1.2k citations) and Pulmonary and Respiratory Medicine (960 citations). Xiaoling Li has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Can Guo, Yong Li, Bo Xiang, Ming Zhou, Yongzhen Mo, Lianxiang Luo and Fang Xiong. Their work appears in journals such as Molecular Cancer, Journal of Biological Chemistry, Journal of Cancer, Journal of Experimental & Clinical Cancer Research and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.